Patents for A61P 19 - Drugs for skeletal disorders (81,981)
12/2008
12/03/2008CN100438909C 化合物 Compound
12/03/2008CN100438894C Donky-hide bone-strengthening composition and its production method
12/03/2008CN100438877C (20s) 1alpha-hydroxy-2alpha-methyl and 2beta-methyl-19-nor-vitamin D3 and their uses
12/02/2008US7459540 Fibroblast growth factor-like polypeptides
12/02/2008US7459470 For example, N-(Isoquinolin-3-yl)-2-(4-pyridylmethyl)aminobenzoic acid amide-N-oxide; use as pharmaceutical agents for treating diseases that are triggered by persistent angiogenesis, such as psoriasis, arthritis, hemangioma, angiofibroma, eye diseases, cirrhosis of the liver
12/02/2008US7459466 Antiinflammatory agents; autoimmune diseases; anticancer agents
12/02/2008US7459464 Triple monoamine reuptake inhibitors for the treatment of chronic pain
12/02/2008US7459459 8-(3-pentylamino)-2-methyl-3-(2-methyl-4-methoxyphenyl)-6,7-dihydro-5H-cyclopenta[d]pyrazolo[1,5-a]pyrimidine; corticotropin releasing factor receptor antagonist; antidepressant, anxiolytic agent; eating disorder, peptic ulcer, irritable bowl syndrome, Alzheimer's disease, drug addiction or alcoholism
12/02/2008US7459453 Pyridazin-3(2H)-one derivatives as PDE4 inhibitors
12/02/2008US7459307 Composition for treatment of articular cartilage damage
12/02/2008US7459300 Expression vector comprising nucleotide sequences coding metastatic tumor element for use in diagnosis, prevention and treatment of renal and cell proliferative disorders
12/02/2008US7459293 Polypeptide of given sequence; stimulating immune system and proliferation or development of hematopoietic cells
12/02/2008US7459291 Chordin-like molecules and uses thereof
12/02/2008US7459173 Medicament for prevention and treatment of bone fracture and osteoporosis
12/02/2008US7459171 Controlling flux of penetrants across adaptable, semipermeable porous barrier by enlarging applied dose per area of penetrants; drug delivery
12/02/2008CA2397404C Micronized freeze-dried particles
12/02/2008CA2394230C Novel stromelysin inhibitors
12/02/2008CA2305548C Prostaglandin agonists and their use to treat bone disorders
11/2008
11/27/2008WO2008144767A1 Heterocyclic kinase modulators
11/27/2008WO2008144754A2 Methods of treating inflammatory disorders using isoforms of receptor tyrosine kinases
11/27/2008WO2008144473A2 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008WO2008144352A1 Threitol phosphates, salts thereof and methods of use
11/27/2008WO2008142376A1 Bicyclosulfonyl acid (bcsa) compounds and their use as therapeutic agents
11/27/2008WO2008141897A1 Composition useful for the prevention of adverse effect due to the use of ppar-gamma agonists
11/27/2008WO2008141511A1 A HUMAN ANTI-TNFα MONOCLONAL ANTIBODY AND THE USE THEREOF
11/27/2008WO2008084282A3 Punica granatum plant extracts for treating osteoporosis and the extraction process thereof
11/27/2008WO2008083367A3 Polycyclic heteroaryl substituted triazoles useful as axl inhibitors
11/27/2008WO2005112981A3 Compositions and methods for the stimulation or enhancement of bone formation and the self-renewal of cells
11/27/2008US20080293962 Novel compounds of the N-acylamino amide family compositions comprising them and uses thereof
11/27/2008US20080293819 N-(1-cyanocyclopropyl)-4,4-difluoro-2(S)-[2,2,2-trifluoro-1(S)-(4-fluorophenyl)ethylamino)octamide; rheumatoid arthritis, multiple sclerosis, myasthenia gravis, psoriasis, pemphigus vulgaris, Graves' disease, myasthenia gravis, lupus, asthma, pain, atherosclerosis; cathepsins B, K, L, F, and S inhibitors
11/27/2008US20080293818 Regulator of Physiological Function of Ghrelin and Use Thereof
11/27/2008US20080293797 Central nervous system disorders; respiratory system disorders; sexual or reproductive disorders; eating disorders; antidiabetic agents; cardiovascular disorders; anticancer agents
11/27/2008US20080293785 Substituted benzothiazole kinase inhibitors
11/27/2008US20080293748 Thioxanthine Derivatives as Myeloperoxidase Inhibitors
11/27/2008US20080293743 (5S)-5-({[6-(2-cyclopropylpyrimidin-5-yl)-3,4-dihydroisoquinolin-2(1H)-yl]sulfonyl}methyl)-5-methylimidazolidine-2,4-dione; asthma, chronic obstructive pulmonary disease
11/27/2008US20080293739 Compounds for modulating t-cells
11/27/2008US20080293732 Substituted pyrazoles
11/27/2008US20080293677 Use of Alternating Amine and Non-Amine Bisphosphonate Combinations For Treating Osteoporosis
11/27/2008US20080293658 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells
11/27/2008US20080293650 Fused Heterocyclic Compounds and Use Thereof
11/27/2008US20080293631 Treatment for Autoimmune and Inflammatory Conditions
11/27/2008US20080292730 Nutritional supplement for osteoarthritis
11/27/2008US20080292667 Nonwoven Nanofibrous Membranes of Silk Fibroin for Guided Bone Tissue Regeneration and Their Preparation Method
11/27/2008US20080292637 Therapeutic Uses of A3 Adenosine Receptor Antibodies
11/27/2008US20080292618 Intranuclear protein transduction through a nucleoside salvage pathway
11/27/2008US20080292614 DNA sequences for human angiogenesis genes
11/27/2008US20080292599 Pluripotent mesenchymal cells artificially enhanced with a LIM mineralization protein fragment necessary for osteoinduction; joint and disk diseases; increased chondrogenic marker expression
11/27/2008US20080292593 Gene therapy for spinal cord disorders
11/27/2008US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof
11/27/2008CA2687903A1 Amino acid sequences directed against rank-l and polypeptides comprising the same for the treatment of bone diseases and disorders
11/27/2008CA2687523A1 Chimeric pufa polyketide synthase systems and uses thereof
11/27/2008CA2687415A1 Bicyclosulfonyl acid (bcsa) compounds and their use as therapeutic agents
11/27/2008CA2687154A1 Composition useful for the prevention of the adverse effect due to the use of ppar-gamma agonists
11/27/2008CA2684758A1 Concentrated protein preparations of bone morphogenetic proteins and methods of use thereof
11/26/2008EP1995243A1 Triazole derivative or salt thereof
11/26/2008EP1994934A1 Therapeutic agent for degenerative arthritis
11/26/2008EP1994155A1 Polynucleotides and polypeptide sequences involved in the process of bone remodeling
11/26/2008EP1993579A2 A pharmaceutical composition for the prevention/treatment of bone disorders and a process for the preparation thereof
11/26/2008EP1993559A2 Treating vitamin d insufficiency and deficiency with 25-hydroxyvitamin d2 and 25-hydroxyvitamin d3
11/26/2008EP1993558A2 Oxysterol compounds and the hedgehog pathway
11/26/2008EP1993550A1 Gsk-3 inhibitors for the treatment of osteoporosis
11/26/2008EP1993544A1 The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain
11/26/2008EP1993525A1 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain
11/26/2008EP1594492B1 Novel inhibitors of formation of advanced glycation endproducts (ages)
11/26/2008EP1515736B1 Compositions against inflammatory processes
11/26/2008EP1496914B1 (20S)-1alpha-HYDROXY-2alpha-METHYL AND 2beta-METHYL-19-NOR-VITAMIN D3 AND THEIR USES
11/26/2008EP1421070B1 New piperidinyl derivates as modulators of chemokine receptor activity
11/26/2008EP1414455B1 Isoquinoline inhibitors of p38
11/26/2008EP1337517B1 Pyrimidinone derivatives and their use in the treatment of atherosclerosis
11/26/2008EP1330452B1 Pyrazine derivatives as modulators of tyrosine kinases
11/26/2008EP0957943B2 Matrix-free osteogenic devices, implants and methods of use thereof
11/26/2008CN101312946A 9-chloro-15-deoxyprostaglandin derivatives, process for their preparation and their use as medicaments
11/26/2008CN101310755A Medicine for promoting the quick cure of fracture and preparation method thereof
11/26/2008CN101310750A External remedy for treating soft tissue injury and preparation method thereof
11/26/2008CN101310730A Use of clostridium butyricum for preparing microbiological preparation for preventing and curing atrophic arthritis, ankylosing spondylitis
11/26/2008CN100436578C Modulation of the transcription of pro-inflammatory gene products
11/26/2008CN100436462C Reaction method of biological alkali, reaction product and use thereof
11/26/2008CN100436452C Pyrazole compounds useful as protein kinase inhibitors
11/26/2008CN100436449C Preparation of pharmaceutical salts of 4((z)-(4-bromophenyl)(ethoxyimino)methyl)-1'-((2,4-dimethyl-1-oxido-3-pyridinyl)carbonyl)-4'-methyl-1,4'bipiperidine as ccr5-antagonists for the treatment of aid
11/26/2008CN100436439C Dimeric isoflavones
11/26/2008CN100435859C Methods and compositions for healing and repair of articular cartilage
11/26/2008CN100435821C Medicine for treating rheumatoid disease
11/26/2008CN100435819C Method for preparing compound corydalis amabilis preparation
11/26/2008CN100435794C Use of 4-[(4-thiazolyl) phenoxl] alkoxy-benzamidine derivatives for treatment of osteoporosis
11/26/2008CN100435656C Fruit and/or vegetable derived composition
11/25/2008US7456286 Bicyclic heteroaromatic compounds as kinase inhibitors
11/25/2008US7456275 Endcapped block polymers including ethylene oxide-propylene oxide, glycolic acid-lactic acid, or ethylene oxide-lactic or glycolic acid; low viscosity allows easy injection; capable of room temperature distribution; extended analgesic effectiveness; nontoxic antiarthritic agents; tissue repair
11/25/2008US7456253 Growth hormone releasing peptides
11/25/2008US7456217 Administering N-(2,6-Dichlorobenzoyl)-4-(2,6-dimethoxy-4-methoxymethylphenyl)-L-phenylalanine ethyl ester for therapy of multiple sclerosis
11/25/2008US7456185 2-amino-6-phenoxy-substituted quinazoline derivatives; treating arthritis, Crohn's disease, Alzeihmer's disease, adult respiratory distress syndrome, chronic obstructive pulmonary disease, asthma, stroke, sepsis, myocardial infarction, and spondylitis
11/25/2008US7456176 Benzotriazine inhibitors of kinases
11/25/2008US7456168 2-(pyridin-2-ylamino)-pyrido[2,3, d]pyrimidin-7-ones
11/25/2008US7456158 4-dedimethylaminotetracycline derivatives
11/25/2008US7456150 Pulmonary delivery of active fragments of parathyroid hormone
11/25/2008US7455835 Administering soluble cytotoxic t-lymphocyte associated antigen (ctla4) molecule that binds a cell surface B7 molecule
11/25/2008CA2414146C Substituted benzamides for immune enhancement and for the treatment of cancer, infection and manic-depressive illness
11/25/2008CA2232986C Bone grafting matrix
11/20/2008WO2008140041A1 Novel antiphlogistic-analgesic agent
11/20/2008WO2008139845A1 Novel amide derivative
11/20/2008WO2008139314A1 Compositions and methods for treating joint disorders